Department of Epidemiology, University of Michigan, School of Public Health, Ann Arbor, MI, USA.
Oral Oncol. 2010 Aug;46(8):591-6. doi: 10.1016/j.oraloncology.2010.05.002. Epub 2010 Jul 8.
Head and neck cancer (HNC) has been studied in different regions of the world but little is known about its incidence patterns in the Middle East and Egypt. In this study from Egypt's only population-based registry, we analyzed data from 1999 to 2006, to estimate incidence, incidence rate ratios (IRRs) and 95% confidence intervals (CIs) categorized by age, district and subsites. Overall urban incidence of HNC was twice or more that of rural incidence for both males (IRR=2.59; 95% CI=2.26, 2.97) and females (IRR=2.00; 95% CI=1.64, 2.43). Highest urban-rural difference for males was seen in 40-49years (IRR=2.79; 95% CI=1.92, 4.05) and for females in 30-39years (IRR=2.94; 95% CI=1.60, 5.40). Among subsites, highest incidence among males was for larynx (1.53/10(5)) and among females for gum and mouth (0.48/10(5)). Maximum urban-rural difference in males was for paranasal sinus (IRR=4.66; 95% CI=1.88, 11.54) and in females for lip (IRR=8.91; 95% CI=1.89, 41.98). The study underscores the patterns of HNC incidence in Egypt while indicating the need for future analytical studies investigating specific risk factors of HNC in this population.
头颈部癌症(HNC)在世界不同地区进行了研究,但对中东和埃及的发病率模式知之甚少。在这项来自埃及唯一的基于人群的登记处的研究中,我们分析了 1999 年至 2006 年的数据,以按年龄、地区和部位分类来估计发病率、发病率比(IRR)和 95%置信区间(CI)。HNC 的城市总体发病率是农村发病率的两倍或更多,男性(IRR=2.59;95%CI=2.26,2.97)和女性(IRR=2.00;95%CI=1.64,2.43)。男性最高的城乡差异出现在 40-49 岁(IRR=2.79;95%CI=1.92,4.05),女性出现在 30-39 岁(IRR=2.94;95%CI=1.60,5.40)。在部位方面,男性发病率最高的是喉(1.53/10(5)),女性发病率最高的是牙龈和口腔(0.48/10(5))。男性最大的城乡差异是发生在副鼻窦(IRR=4.66;95%CI=1.88,11.54),女性最大的城乡差异是发生在嘴唇(IRR=8.91;95%CI=1.89,41.98)。该研究强调了埃及 HNC 发病率的模式,同时表明需要对该人群的 HNC 特定风险因素进行未来的分析研究。
Indian J Cancer. 2012
Asian Pac J Cancer Prev. 2006
Cancer Epidemiol. 2009-9-16
Asian Pac J Cancer Prev. 2008
Technol Cancer Res Treat. 2025
Cureus. 2024-1-5
Cancer Epidemiol. 2009-9-16
East Mediterr Health J. 2009
Breast Cancer Res Treat. 2009-6-23
Curr Opin Oncol. 2009-5
East Mediterr Health J. 2008
Cancer Epidemiol Biomarkers Prev. 2008-8